D. End-organ resistance to PTH due to impaired Gs-alpha signaling associated with GNAS
Why this is correct
Pseudohypoparathyroidism features resistance of target tissues, especially the kidney, to PTH despite elevated circulating hormone. Certain GNAS-related forms affect the stimulatory G protein alpha subunit used by the PTH receptor, reducing downstream cAMP signaling. The findings of Albright hereditary osteodystrophy—short stature, round face and shortened fourth/fifth metacarpals—support this diagnosis. Impaired PTH-induced renal phosphate excretion produces hyperphosphatemia and contributes to hypocalcemia.
Why each option is correct or incorrect
Primary hypoparathyroidism would generally have low or inappropriately normal PTH rather than pronounced elevation.
Excess calcitriol more often increases calcium absorption and is not the dominant cause of the PTH-resistance phenotype.
CaSR gain-of-function can suppress PTH causing autosomal dominant hypocalcemia, rather than high PTH with Albright features.
Correct: impaired PTH receptor–Gs–cAMP signaling produces target-organ resistance.
High-yield notes
- Pseudohypoparathyroidism: low calcium, high phosphate and elevated PTH.
- GNAS-related Gs-alpha signaling defects can cause PTH resistance.
- Albright hereditary osteodystrophy includes brachydactyly and short stature.
High PTH with hypocalcemia and high phosphate suggests PTH resistance rather than absent hormone production.
Albright hereditary osteodystrophy can exist without all biochemical features of hormone resistance in related GNAS phenotypes.